Prosecution Insights
Last updated: April 19, 2026
Application No. 17/576,080

MEDICAL DRAINAGE STENT

Non-Final OA §103
Filed
Jan 14, 2022
Examiner
STRACHAN, KATE ELIZABETH
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Micro-Tech (Nanjing) Co. Ltd.
OA Round
5 (Non-Final)
41%
Grant Probability
Moderate
5-6
OA Rounds
4y 0m
To Grant
71%
With Interview

Examiner Intelligence

Grants 41% of resolved cases
41%
Career Allow Rate
33 granted / 81 resolved
-29.3% vs TC avg
Strong +31% interview lift
Without
With
+30.6%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
68 currently pending
Career history
149
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
69.8%
+29.8% vs TC avg
§102
16.9%
-23.1% vs TC avg
§112
9.6%
-30.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 81 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 12/5/2025 has been entered. Status of Claims Claims 1-6 and 8-21 are pending and currently under consideration for patentability. Claims 1, 2, 13, and 21 have been amended. Claim 7 remains canceled without prejudice or disclaimer. Priority Acknowledgment is made of applicant’s claim for foreign priority under 35 U.S.C. 119 (a)-(d). Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Response to Arguments Applicant's arguments filed 12/5/2025 have been fully considered but they are not persuasive. The applicant argues that the combination fails to teach: (1) the extension portion is independent of the stent body, and is an internally hollow arc- shaped tube connected to the proximal end of the stent body; and (2) the extension portion has two ends, where the fixed end is fixedly connected with the edge of the proximal end of the stent body and the free end in a free state; and a partial region of the extension portion that occupies 1/3 of a total length of the arc-shaped tube is fixedly connected with the stent body along a spiral direction of the extension portion from the fixed end of the extension portion. In response to argument (1) that the references fail to show certain features of the invention, it is noted that the features upon which applicant relies (i.e., internally hollow tubes) are not recited in the rejected claim(s). Although the claims are interpreted in light of the specification, limitations from the specification are not read into the claims. See In re Van Geuns, 988 F.2d 1181, 26 USPQ2d 1057 (Fed. Cir. 1993). In response to argument (2) it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have explicitly a partial region of the extension portion at least occupying 1/3 of a total length of the arc-shaped tube in order to fit the particular procedure being done since this claimed dimension of the total length is not critical. Since applicant has not given any criticality to why the dimension disclosed has any importance to the function of the claimed device (see page 3, paragraphs= 1 of applicants specification), the Federal Circuit held that, where the only difference between the prior art and the claims was a recitation of relative dimensions of the claimed device and a device having the claimed relative dimensions would not perform differently than the prior art device, the claimed device was not patentably distinct from the prior art device. In Gardner v. TEC Syst., Inc., 725 F.2d 1338, 220 USPQ 777. In response to applicant's arguments against the references individually, one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986). In response to applicant’s argument that there is no teaching, suggestion, or motivation to combine the references, the examiner recognizes that obviousness may be established by combining or modifying the teachings of the prior art to produce the claimed invention where there is some teaching, suggestion, or motivation to do so found either in the references themselves or in the knowledge generally available to one of ordinary skill in the art. See In re Fine, 837 F.2d 1071, 5 USPQ2d 1596 (Fed. Cir. 1988), In re Jones, 958 F.2d 347, 21 USPQ2d 1941 (Fed. Cir. 1992), and KSR International Co. v. Teleflex, Inc., 550 U.S. 398, 82 USPQ2d 1385 (2007). In this case, Li is not being modified by Binmoeller, Binmoeller needs to be modified by Li, so there is not destroying the intended use of Li. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-13, 15, 16, 18-19 and 21is/are rejected under 35 U.S.C. 103 as being unpatentable over Binmoeller (US 20180289463 A1) in view of Li (CN 106880429 B). Regarding Claim 1, Binmoeller teaches a medical drainage stent (medical drainage stent)(figures 13A-16D), comprising: a stent body (170), and a proximal portion and a distal portion that are located at two ends of the stent body configured to connect a first region and a second region in a juxtaposing manner (paragraph [0027]), the stent body being fixed between the first region and the second region to provide a drainage channel (paragraph [0032]), wherein the proximal portion of the stent has N extension portions (flange structure 171)(figure 15A-15C), a fixed end of the extension portion being fixedly connected with an edge of a proximal end (downstream flange/ proximal edge, paragraph [0019])) of the stent body (170) (annotated figure 15B). structures of the N extension portions (171) at least partially protrude from the stent body in a radial direction (figure 15B) so that the proximal portion of the stent is fixed on the first region, wherein N (N =2) is a positive integer. An alternative embodiment of Binmoeller teaches the other end of the extension portion being a free end in a free state, the other end is a free end in a free state; (distal end is free until flange is deployed (paragraph [0031-32]). It would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to combine the embodiments Binmoeller to include a free end portion so that stent may be easily inserted. PNG media_image1.png 451 507 media_image1.png Greyscale PNG media_image2.png 432 386 media_image2.png Greyscale Binmoeller fails to teach wherein the extension portion is an arc-shaped tube extending spirally along the edge of the proximal end of the stent body; the fixed end of the arc-shaped tube is fixed at the edge of the proximal end of the stent body; the other end is a free end in a free state; and a partial region of the extension portion at least occupying 1/3 of a total length of the arc-shaped tube is fixedly connected with the edge of the proximal end of the stent body along a spiral direction of the extension portion from the fixed end of the extension portion. Li teaches a spiral vascular bracket wherein the extension portion is an arc-shaped tube extending spirally along the edge of the proximal end of the stent body (abstract)(figure 2); the fixed end of the arc-shaped tube is fixed at the edge of the proximal end of the stent body (“the spiral vascular bracket two ends of helix 1 for curve 1 asmoothly connecting to integrally form a closed state”); the other end is a free end in a free state (open spiral ends, figure 2 and 3)(claim 1); the arc-shaped tube is fixedly connected with the edge of the proximal end of the stent body along a spiral direction of the extension portion from the fixed end of the extension portion (open spiral ends, figure 2 and 3). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify the stent of Binmoeller to have the extension portion is an arc-shaped tube extending spirally along the edge of the proximal end of the stent body; the fixed end of the arc-shaped tube is fixed at the edge of the proximal end of the stent body; the other end is a free end in a free state; and a partial region of the extension portion at least occupying 1/3 of a total length of the arc-shaped tube is fixedly connected with the edge of the proximal end of the stent body along a spiral direction of the extension portion from the fixed end of the extension portion, similar to Binmoeller so that the stent is both flexible and supported. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have explicitly a partial region of the extension portion at least occupying 1/3 of a total length of the arc-shaped tube in order to fit the particular procedure being done since this claimed dimension of the total length is not critical. Since applicant has not given any criticality to why the dimension disclosed has any importance to the function of the claimed device (see page 3, paragraphs= 1 of applicants specification), the Federal Circuit held that, where the only difference between the prior art and the claims was a recitation of relative dimensions of the claimed device and a device having the claimed relative dimensions would not perform differently than the prior art device, the claimed device was not patentably distinct from the prior art device. In Gardner v. TEC Syst., Inc., 725 F.2d 1338, 220 USPQ 777. Regarding Claim 2, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 1. Binmoeller further teaches wherein a structure of the arc-shaped tube partially protrudes from the stent body in the radial direction (171), so that the proximal portion of the stent is fixed on the first region (figure 15B)(paragraph [0083]). Regarding Claim 3, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 1. Binmoeller further teaches wherein the extension portion extends outward along a radial direction of the stent body figure 15B)(paragraph [0083]), the fixed end thereof is fixed at the edge of the proximal end of the stent body (downstream flange), and the other end is a free end in a free state (distal end is free until flange is deployed (paragraph [0031-32])). Regarding Claim 4, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 1. Binmoeller further teaches wherein all the extension portions are evenly arranged at the edge of the proximal end of the stent body (figure 15B), and an included angle between two adjacent extension portions is 360/N degrees, wherein N is a positive integer from 2 to 4 (right angles are 90 degrees. (360/4)) (paragraph [0080]) Regarding Claim 5, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 2. Binmoeller further teaches wherein all the extension portions are evenly arranged at the edge of the proximal end of the stent body (figure 15B), and an included angle between two adjacent extension portions is 360/N degrees, wherein N is a positive integer from 2 to 4 (right angles are 90 degrees. (360/4)) (paragraph [0080]) Regarding Claim 6, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 3. Binmoeller further teaches wherein all the extension portions are evenly arranged at the edge of the proximal end of the stent body (figure 15B), and an included angle between two adjacent extension portions is 360/N degrees, wherein N is a positive integer from 2 to 4 (right angles are 90 degrees. (360/4)) (paragraph [0080]) Regarding Claim 8, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 2. Binmoeller further teaches wherein the free end of the extension portion is provided with a fixing structure for fixedly connecting the free end to the first region (paragraph [0037]), wherein the fixing structure and the free end are fixedly or not fixedly connected (distal end is free until flange is deployed (paragraph [0031-32])) and supporting force of the fixing structure is greater than that of the extension portion (paragraph [0051: pullout force can be greater than 9.8N)]) (paragraph [0004: down steam flange structure have a force of about 2.49 N]). Regarding Claim 9, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 3. Binmoeller further teaches wherein the free end of the extension portion is provided with a fixing structure for fixedly connecting the free end to the first region (paragraph [0037]), wherein the fixing structure and the free end are fixedly or not fixedly connected (distal end is free until flange is deployed (paragraph [0031-32])) and supporting force of the fixing structure is greater than that of the extension portion (paragraph [0051: pullout force can be greater than 9.8N)]) (paragraph [0004: down steam flange structure have a force of about 2.49 N]). Regarding Claim 10, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 1. Binmoeller further teaches a retrieval loop provided at the proximal portion and/or the distal portion of the stent (paragraph [0033]). The claim language only requires the prior art to disclose one of the claim structures, therefore “the developing member provided on the stent to display a position of the stent under rays” is not required. Regarding Claim 11, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 2. Binmoeller further teaches a retrieval loop provided at the proximal portion and/or the distal portion of the stent (paragraph [0033]). The claim language only requires the prior art to disclose one of the claim structures, therefore “the developing member provided on the stent to display a position of the stent under rays” is not required. Regarding Claim 12, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 3. Binmoeller further teaches a retrieval loop provided at the proximal portion and/or the distal portion of the stent (paragraph [0033]). The claim language only requires the prior art to disclose one of the claim structures, therefore “the developing member provided on the stent to display a position of the stent under rays” is not required. Regarding Claim 13, Binmoeller teaches a medical drainage stent (medical drainage stent)(figures 13A-16D), comprising: a stent body (170), and a proximal portion and a distal portion that are located at two ends of the stent body configured to connect a first region and a second region in a juxtaposing manner (paragraph [0027]), the stent body being fixed between the first region and the second region to provide a drainage channel (paragraph [0032]), wherein the stent body has a flexible portion (172) whose supporting force is smaller than that of the proximal portion and the distal portion (paragraph [0039]); and the flexible portion is able to form a recess with a reduced inner diameter after being pressed (paragraph [0039]), so that structures of the proximal portion and the distal portion of the stent partially protrude from the stent body(paragraph [0039]), and that the proximal portion of the stent is fixed on the first region, and the distal portion is fixed on the second region (paragraph [0053]). The primary embodiment of Binmoeller fails to teach wherein the flexible portion is able to form a recess with a reduced inner diameter after being pressed, so that structures of the proximal portion and the distal portion of the stent partially protrude from the stent body, and that the proximal portion of the stent is fixed on the first tissue wall, and the distal portion is fixed on the second tissue wall. It would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to combine the embodiments Binmoeller to create flanges at the desired location depending on the procedure. Binmoeller fails to teach wherein the extension portion is an arc-shaped tube extending spirally along the edge of the proximal end of the stent body; the fixed end of the arc-shaped tube is fixed at the edge of the proximal end of the stent body; the other end is a free end in a free state; and a partial region of the extension portion at least occupying 1/3 of a total length of the arc-shaped tube is fixedly connected with the edge of the proximal end of the stent body along a spiral direction of the extension portion from the fixed end of the extension portion. In the same field of endeavor, Li teaches an anti-displacement anesthetic catheter wherein the extension portion is an arc-shaped tube (airbag 2) extending spirally along the edge of the proximal end of the stent body(1) (figures 1-3); the fixed end of the arc-shaped tube is fixed at the edge of the proximal end of the stent body (1) (page 3); the arc-shaped tube is fixedly connected with the edge of the proximal end of the stent body along a spiral direction of the extension portion from the fixed end of the extension portion (figure 3)(page 3). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to have the extension loop down the stent similar to Li to prevent displacement of the catheter (as motivated by Li, page 2). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have explicitly a partial region of the extension portion at least occupying 1/3 of a total length of the arc-shaped tube in order to fit the particular procedure being done since this claimed dimension of the total length is not critical. Since applicant has not given any criticality to why the dimension disclosed has any importance to the function of the claimed device (see page 3, paragraphs= 1 of applicants specification), the Federal Circuit held that, where the only difference between the prior art and the claims was a recitation of relative dimensions of the claimed device and a device having the claimed relative dimensions would not perform differently than the prior art device, the claimed device was not patentably distinct from the prior art device. In Gardner v. TEC Syst., Inc., 725 F.2d 1338, 220 USPQ 777. Regarding Claim 15, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 13. Binmoeller further teaches wherein the flexible portion (172) covers a part of a region of the stent body (figures 15A-15B)(paragraph [0083]), and supporting force of the remaining region of the stent body is greater than that of the flexible portion (paragraph [0039]). Regarding Claim 16, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 13. Binmoeller further teaches wherein the proximal portion and the distal portion of the stent have fixing structures (flange structure 171)(figure 15A-15C) protruding from the stent body (170) (paragraph [0083]). Regarding Claim 18, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 15. Binmoeller further teaches wherein the proximal portion and the distal portion of the stent have fixing structures (flange structure 171)(figure 15A-15C) protruding from the stent body (170) (paragraph [0083]). Regarding Claim 19, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 13. Binmoeller further teaches a retrieval loop provided at the proximal portion and/or the distal portion of the stent (paragraph [0033]). The claim language only requires the prior art to disclose one of the claim structures, therefore “the developing member provided on the stent to display a position of the stent under rays” is not required. Regarding Claim 21, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 14. The combination further teaches wherein the free end of the extension portion is provided with a fixing structure for fixedly connecting the free end to the first region, wherein the fixing structure and the free end are fixedly or not fixedly connected, and a supporting force of the fixing structure is greater than that of the extension portion (paragraph [0051-0052]). Claim(s) 14, 17, and 20 are rejected under 35 U.S.C. 103 as being unpatentable over Binmoeller (US 20180289463 A1) in view of Li (CN 106880429 B) in view of Amplantz (US-9039724-B2). Regarding Claim 14, the combination of Binmoeller in view of Li teaches the medical drainage stent according to claim 13. Binmoeller fails to teach wherein the stent body has more than two flexible portions that extend along an axial direction of the stent body, and the flexible portions are distributed at equal intervals in a circumferential direction of the stent body. Amplantz teaches wherein the stent body has more than two flexible portions that extend along an axial direction of the stent body, and the flexible portions are distributed at equal intervals in a circumferential direction of the stent body (A has sections 412a, 412b, 412c). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify the stent body of Binmoeller to include flexible portions distributed at even intervals similar to that disclosed by Amplantz so that the user may choose exactly where to place the flanges for optimal use. Regarding Claim 17, the combination of Binmoeller in view of Amplantz teaches the medical drainage stent according to claim 14. Binmoeller further teaches wherein the proximal portion and the distal portion of the stent have fixing structures (flange structure 171)(figure 15A-15C) protruding from the stent body (170) (paragraph [0083]). Regarding Claim 20, the combination of Binmoeller in view of Amplantz teaches the medical drainage stent according to claim 14. Binmoeller further teaches a retrieval loop provided at the proximal portion and/or the distal portion of the stent (paragraph [0033]). The claim language only requires the prior art to disclose one of the claim structures, therefore “the developing member provided on the stent to display a position of the stent under rays” is not required. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATE ELIZABETH STRACHAN whose telephone number is (571)272-7291. The examiner can normally be reached M-F: 8:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rebecca Eisenberg can be reached on (571)-270-5879. The fax phone number for the organization where this application or proceeding is assigned is (571)-270-5879. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATE ELIZABETH STRACHAN/ Examiner, Art Unit 3781 /REBECCA E EISENBERG/Supervisory Patent Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Jan 14, 2022
Application Filed
Apr 11, 2024
Non-Final Rejection — §103
Jul 02, 2024
Response Filed
Oct 03, 2024
Final Rejection — §103
Nov 26, 2024
Response after Non-Final Action
Dec 09, 2024
Response after Non-Final Action
Dec 27, 2024
Response after Non-Final Action
Jan 09, 2025
Request for Continued Examination
Jan 10, 2025
Response after Non-Final Action
May 01, 2025
Non-Final Rejection — §103
Jul 09, 2025
Response Filed
Oct 18, 2025
Final Rejection — §103
Dec 05, 2025
Response after Non-Final Action
Jan 23, 2026
Request for Continued Examination
Feb 18, 2026
Response after Non-Final Action
Mar 04, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599712
ELECTRO-MECHANICAL PUMP CONTROLLER FOR NEGATIVE-PRESSURE TREATMENT
2y 5m to grant Granted Apr 14, 2026
Patent 12539393
CATHETER
2y 5m to grant Granted Feb 03, 2026
Patent 12527949
SYSTEMS AND METHODS FOR PUMPING SALINE THROUGH A STERILIZING FILTER
2y 5m to grant Granted Jan 20, 2026
Patent 12521343
Two Stage Microchip Drug Delivery Device and Methods
2y 5m to grant Granted Jan 13, 2026
Patent 12478708
WOUND CARE DEVICE HAVING FLUID TRANSFER AND ADHESIVE PROPERTIES
2y 5m to grant Granted Nov 25, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
41%
Grant Probability
71%
With Interview (+30.6%)
4y 0m
Median Time to Grant
High
PTA Risk
Based on 81 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month